186
Views
0
CrossRef citations to date
0
Altmetric
Research Aricles

Circulating levels of transforming growth factor beta-1, 2 and 3 in HIV associated preeclamptic pregnancies

, &

References

  • Adu-Gyamfi EA, Lamptey J, Duan F, Wang Y-X, Ding Y-B. 2019. The transforming growth factor β superfamily as possible biomarkers of preeclampsia: a comprehensive review. Biomarkers in Medicine 13:1321–1330.
  • Alam S, Ahmad S, Zafeer F, Rizvi AA, Gulati R, Rashid S. 2017. Role of TGF-Β1 in the pathogenesis of pre-eclampsia. Annals of International Medical Dental Research 3:1.
  • Alese MO, Moodley J, Naicker TA. 2019. Signalling of ERK1/2, P38MAPK and P90RSK in HIV-associated pre-eclampsia. Journal of Obstetrics and Gynaecology 39:612–618.
  • Althabe F, Moore JL, Gibbons L, Berrueta M, Goudar SS, Chomba E, et al. 2015. Adverse maternal and perinatal outcomes in adolescent pregnancies: the Global Network’s Maternal Newborn Health Registry study. Reproductive Health 12:S8.
  • Annes JP, Munger JS, Rifkin DB. 2003. Making sense of latent TGFβ activation. Journal of Cell Science 116:217–224.
  • Attisano L, Wrana JLJS. 2002. Signal transduction by the TGF-β superfamily. Science 296:1646–1647.
  • Ayatollahi M, Geramizadeh B, Samsami A. 2015. Transforming growth factor beta-1 influence on fetal allografts during pregnancy. Transplantation Proceedings 37:4603–4604.
  • Bergström S, Povey G, Songane F, Ching C. 1992. Seasonal incidence of eclampsia and its relationship to meteorological data in Mozambique. Journal of Perinatal Medicine 20:153–158.
  • Bian X, Biswas A, Huang X, Lee KJ, Li TK-T, Masuyama H, et al. 2019. Short-Term prediction of adverse outcomes using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) ratio in Asian women with suspected preeclampsia. Hypertension 74:164–172.
  • Brown MA, Magee LA, Kenny LC, Karumanchi SA, Mccarthy FP, Saito S, et al. 2018. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Hypertension 72:24–43.
  • Caillon H, Tardif C, Dumontet E, Winer N, Masson D. 2018. Evaluation of sFlt-1/PlGF ratio for predicting and improving clinical management of pre-eclampsia: experience in a specialized perinatal care center. Annals of Laboratory Medicine 38:95–101.
  • Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ. 1999. Inhibition of TGF-β 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. The Journal of Clinical Investigation 103:1641–1650.
  • Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M, Post M. 2000. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ 3. The Journal of Clinical Investigation 105:577–587.
  • Caniggia I, Taylor CV, Ritchie JK, Lye SJ, Letarte M. 1997. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology 138:4977–4988.
  • Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. 2014. Pre-eclampsia part 1: current understanding of its pathophysiology. Nature Reviews. Nephrology 10:466–480.
  • Chen Q, Chen L, Liu B, Vialli C, Stone P, Ching LM, Chamley L. 2010. The role of autocrine TGFβ1 in endothelial cell activation induced by phagocytosis of necrotic trophoblasts: a possible role in the pathogenesis of pre‐eclampsia. The Journal of Pathology 221:87–95.
  • Dahmani A, Delisle J-S. 2018. TGF-β in T cell biology: implications for cancer immunotherapy. Cancers 10:194.
  • Davies EL, Bell JS, Bhattacharya S. 2016. Preeclampsia and preterm delivery: a population-based case–control study. Hypertension in Pregnancy 35:510–519.
  • Department of Health. 2012. The 2012 national antenatal sentinel HIV and herpes simplex type-2 prevalence survey in South Africa. South Africa: National Department of Health, Pretoria.
  • Department of Health. 2017. 2015 national antenatal sentinel HIV and syphilis survey report. South Africa: National Department of Health Pretoria.
  • Eder IE, Stenzl A, Hobisch A, Cronauer MV, Bartsch G, Klocker H. 1996. Transforming growth factors-beta 1 and beta 2 in serum and urine from patients with bladder carcinoma. The Journal of Urology 156:953–957.
  • Ellenrieder V, Buck A, Harth A, Jungert K, Buchholz M, Adler G, et al. 2004. KLF11 mediates a critical mechanism in TGF-β signaling that is inactivated by Erk-MAPK in pancreatic cancer cells. Gastroenterology 127:607–620.
  • Enquobahrie DA, Williams MA, Qiu C, Woelk GB, Mahomed K. 2005. Maternal plasma transforming growth factor-β1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women. The Journal of Maternal-Fetal & Neonatal Medicine 17:343–348.
  • Goumans M-J, Mummery C. 2002. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. International Journal of Developmental Biology 44:253–265.
  • Govender N, Naicker T, Moodley J. 2013. Maternal imbalance between pro-angiogenic and anti-angiogenic factors in HIV-infected women with pre-eclampsia. Cardiovascular Journal of Africa 24:174–179.
  • Graham CH, Lala PK. 1991. Mechanism of control of trophoblast invasion in situ. Journal of Cellular Physiology 148:228–234.
  • Graham CH, Lysiak JJ, Mccrae KR, Lala PK. 1992. Localization of transforming growth factor-β at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biology of Reproduction 46:561–572.
  • Hennessy A, Orange S, Willis N, Painter DM, Child A, Horvath JS. 2002. Transforming growth factor‐β1 does not relate to hypertension in pre‐eclampsia. Clinical and Experimental Pharmacology & Physiology 29:968–971.
  • Huang F, Chen Y-G. 2012. Regulation of TGF-β receptor activity. Cell & Bioscience 2:9–10.
  • Huber A, Hefler L, Tempfer C, Zeisler H, Lebrecht A, Husslein P. 2002. Transforming growth factor‐beta 1 serum levels in pregnancy and pre‐eclampsia. Acta Obstetricia et Gynecologica Scandinavica 81:168–171.
  • Jebbink J, Wolters A, Fernando F, Afink G, Van Der Post J, Ris-Stalpers C. 2012. Molecular genetics of preeclampsia and HELLP syndrome—a review. Biochimica et Biophysica Acta 1822:1960–1969.
  • Joint United Nations Programme on Hiv/Aids. 2017. UNAIDS data 2017. Geneva, Switzerland: UNAIDS.
  • Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, et al. 2009. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. The Lancet 374:979–988.
  • Kulkarni AB, Huh C-G, Becker D, Geiser A, Lyght M, Flanders KC, et al. 1993. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proceedings of the National Academy of Sciences of the United States of America 90:770–774.
  • Larsson J, Goumans MJ, Sjöstrand LJ, Van Rooijen MA, Ward D, Levéen P, et al. 2001. Abnormal angiogenesis but intact hematopoietic potential in TGF‐β type I receptor‐deficient mice. The EMBO Journal 20:1663–1673.
  • Li X, Shen L, Tan H. 2014. Polymorphisms and plasma level of transforming growth factor-beta 1 and risk for preeclampsia: a systematic review. PLOS One 9:e97230.
  • Lotz M, Clark-Lewis I, Ganu V. 1994. HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes. The Journal of Cell Biology 124:365–371.
  • Lyall F, Simpson H, Bulmer JN, Barber A, Robson SC. 2001. Transforming growth factor-β expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction. The American Journal of Pathology 159:1827–1838.
  • Mclennan IS, Koishi K. 2004. Fetal and maternal transforming growth factor-β1 may combine to maintain pregnancy in mice. Biology of Reproduction 70:1614–1618.
  • Menkhorst E, Salamonsen LA, Zhang J, Harrison CA, Gu J, Dimitriadis E. 2010. Interleukin 11 and activin A synergise to regulate progesterone-induced but not cAMP-induced decidualization. Journal of Reproductive Immunology 84:124–132.
  • Moodley J, Soma-Pillay P, Buchmann E, Pattinson R. 2019. Hypertensive disorders in pregnancy: 2019 National guideline. South African Medical Journal 109:S3–S16.
  • Mrema D, Lie RT, Østbye T, Mahande MJ, Daltveit AK. 2018. The association between pre pregnancy body mass index and risk of preeclampsia: a registry based study from Tanzania. BMC Pregnancy and Childbirth 18:1–8.
  • Muy-Rivera M, Sanchez SE, Vadachkoria S, Qiu C, Bazul V, Williams MA. 2004. Transforming growth factor-β1 (TGF-β1) in plasma is associated with preeclampsia risk in Peruvian women with systemic inflammation. American Journal of Hypertension 17:334–338.
  • Naicker T, Dorsamy E, Ramsuran D, Burton GJ, Moodley J. 2013. The role of apoptosis on trophoblast cell invasion in the placental bed of normotensive and preeclamptic pregnancies. Hypertension in Pregnancy 32:245–256.
  • Naicker T, Khedun S, Moodley J. 2002. Transforming growth factor β 1 levels in platelet depleted plasma in African women with pre-eclampsia. Journal of Obstetrics and Gynaecology 22:279–282.
  • National Research Council, Rasmussen KM, Yaktine AL, Food and Nutrition Board, Institute of Medicine. 2010. Weight gain during pregnancy: reexamining the guidelines. National Academies Press.
  • Osuji FN, Onyenekwe CC, Ahaneku JE, Ukibe NR. 2018. The effects of highly active antiretroviral therapy on the serum levels of pro-inflammatory and anti-inflammatory cytokines in HIV infected subjects. Journal of Biomedical Science 25:1–8.
  • Park S-H. 2005. Fine tuning and cross-talking of TGF-β signal by inhibitory Smads. Journal of Biochemistry and Molecular Biology 38:9–16.
  • Parra-Saavedra M, Crovetto F, Triunfo S, Savchev S, Peguero A, Nadal A, et al. 2013. Placental findings in late-onset SGA births without doppler signs of placental insufficiency. Placenta 34:1136–1141.
  • Perucci LO, Gomes KB, Freitas LG, Godoi LC, Alpoim PN, Pinheiro MB, et al. 2014. Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia. PLOS One 9:e97632.
  • Poggi A, Zocchi MR. 2006. HIV-1 Tat triggers TGF-β production and NK cell apoptosis that is prevented by pertussis toxin B. Clinical & Developmental Immunology 13:369–372.
  • Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, et al. 1995. Transforming growth factor–β3 is required for secondary palate fusion. Nature Genetics 11:409–414.
  • Reinhold D, Wrenger S, Kähne T, Ansorge S. 1999. HIV-1 Tat: immunosuppression via TGF-β1 induction. Immunology Today 20:384–385.
  • Roberts JM, Hubel CA. 2009. The two stage model of preeclampsia: variations on the theme. Placenta 30:32–37.
  • Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, et al. 2008. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. The Journal of Maternal-Fetal & Neonatal Medicine 21:9–23.
  • Ruscetti FW, Palladino MA. 1991. Transforming growth factor-β and the immune system. Progress in Growth Factor Research 3:159–175.
  • Sahay AS, Patil VV, Sundrani DP, Joshi AA, Wagh GN, Gupte SA, Joshi SR. 2014. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia. Hypertension Research 37:753–758.
  • Schlembach D, Hund M, Schroer A, Wolf C. 2018. Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany. BMC Health Services Research 18:603.
  • Shaarawy M, Meleigy ME, Rasheed K. 2001. Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome. Journal of the Society for Gynecologic Investigation 8:27–31.
  • Shirai Y, Kawata S, Tamura S, Ito N, Tsushima H, Takaishi K, et al. 1994. Plasma transforming growth factor‐β1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases. Cancer 73:2275–2279.
  • Singh AM, Reynolds D, Cliff T, Ohtsuka S, Mattheyses AL, Sun Y, et al. 2012. Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell 10:312–326.
  • Sohlberg S, Stephansson O, Cnattingius S, Wikström A-K. 2012. Maternal body mass index, height, and risks of preeclampsia. American Journal of Hypertension 25:120–125.
  • Statistics South Africa. 2020. Mid-year population estimates 2020. Pretoria, South Africa: Statistics South Africa
  • Tessema GA, Tekeste A, Ayele TA. 2015. Preeclampsia and associated factors among pregnant women attending antenatal care in Dessie referral hospital, Northeast Ethiopia: a hospital-based study. BMC Pregnancy and Childbirth 15:1–7.
  • Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al. 2006. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nature Medicine 12:642–649.
  • Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, et al. 2010. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. American Journal of Obstetrics and Gynecology 202:161.e1–161.e11.
  • Wiercińska-Drapalo A, Flisiak R, Jaroszewicz J, Prokopowicz D. 2004. Increased plasma transforming growth factor-β 1 is associated with disease progression in HIV-1-infected patients. Viral Immunology 17:109–113.
  • Wrighton KH, Lin X, Feng X-H. 2009. Phospho-control of TGF-β superfamily signaling. Cell Research 19:8–20.
  • Xiong X, Demianczuk NN, Saunders LD, Wang F-L, Fraser WD. 2002. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. American Journal of Epidemiology 155:203–209.
  • Xu J, Sivasubramaniyam T, Yinon Y, Tagliaferro A, Ray J, Nevo O, et al. 2016. Aberrant TGFβ signaling contributes to altered trophoblast differentiation in preeclampsia. Endocrinology 157:883–899.
  • Yinon Y, Nevo O, Xu J, Many A, Rolfo A, Todros T, et al. 2008. Severe IUGR pregnancies have increased placental endoglin levels: hypoxic regulation via TGFbeta3. The American Journal of Pathology 172:77–85.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.